Protagonist TherapeuticsvsUnitedHealth

PTGX and UNH stock compared: price, dividend, valuation and results, from SEC filings.

PTGX

Protagonist Therapeutics, Inc.

$121.40

Value $7.7B

-2.47%
PTGX's page

UNH

UnitedHealth Group Incorporated

$339.85

Value $308B

-5.55%
UNH's page

Protagonist Therapeutics (PTGX) has a market value of $7.7B and UnitedHealth (UNH) $308B. Over the last year, with dividends, PTGX moved +47.0% and UNH +8.2%. The P/E is 22.6 for PTGX and 19.4 for UNH. Dividend yield: PTGX none, UNH 2.67%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    PTGX$7.7B

    UNH$308B

    UNH is 40 times PTGX

  • Revenue, 12 months

    PTGX$552M

    UNH$450B

    UNH is 815 times PTGX

  • Net income, 12 months

    PTGX$342M

    UNH$15.9B

    UNH is 46 times PTGX

  • Operating margin

    PTGX58.6%

    UNH5.3%

    53.3 points apart

  • ROIC

    PTGX33.2%

    UNH11.3%

    21.9 points apart

  • P/E

    PTGX22.6

    UNH19.4

    PTGX is 1.2 times UNH

  • Dividend yield

    PTGX0.0%

    UNH2.7%

    2.7 points apart

  • 5-year return

    PTGX+240.6%

    UNH-19.5%

    260.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

PTGX+240.6%

UNH-19.5%

020040020222023202420252026
Returns by period
PeriodPTGXWith dividendsUNHWith dividends
1 year since November 18, 2025+47.0%Price +47.0%+8.2%Price +5.4%
3 years since November 17, 2023+637.8%+94.7% a yearPrice +637.8%-34.4%-13.1% a yearPrice -38.4%
5 years since November 18, 2021+240.6%+27.8% a yearPrice +240.6%-19.5%-4.2% a yearPrice -26.5%
10 years since November 21, 2016+392.1%+17.3% a yearPrice +392.1%+159.4%+10.0% a yearPrice +119.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

PTGXProtagonist TherapeuticsUNHUnitedHealth

Valuation

PTGXUNH
Valuation
Price$121.40$339.85
Market value$7.7B$308B
Enterprise value (EV)$6.9B$354B
P/E22.619.4
P/E, 5-year median–25.0
P/B7.13.0
EV/EBIT21.514.8
Free cash flow yield1.4%7.4%

Results and growth

PTGXUNH
Results and growth
Revenue, 12 months$552M$450B
Net income, 12 months$342M$15.9B
Free cash flow, 12 months$109M$22.8B
Earnings per share, 12 months$5.36$17.52
Revenue growth, year on year-89.4%11.8%
Revenue growth a year, past+10.0%over 5 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

PTGXUNH
Margins and returns on capital
Gross margin–88.3%
Operating margin58.6%5.3%
Net margin62.0%3.5%
ROIC33.2%11.3%
ROE44.5%15.5%

Balance sheet

PTGXUNH
Balance sheet
Cash$800M$28.5B
Total debt$8.6M$74.3B
Net debt / EBITDA-2.51.6
Interest cover–6.2×

Dividends and buybacks

PTGXUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield–4.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: PTGX or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Protagonist Therapeutics or UnitedHealth?

By market value, UnitedHealth ($308B) is about 39.8 times Protagonist Therapeutics ($7.7B), at today's prices.

How did PTGX and UNH stock do over the last 10 years?

Since November 21, 2016, PTGX's price moved +392.1% and UNH's +119.7%. With dividends: PTGX +392.1% (+17.3% a year), UNH +159.4% (+10.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, PTGX or UNH?

The dividend yield at today's price is none for Protagonist Therapeutics and 2.67% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

What is the P/E of PTGX and UNH?

At today's price, the P/E is 22.6 for PTGX and 19.4 for UNH. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Protagonist Therapeutics or UnitedHealth?

Over the last twelve months, the net margin was 62.0% for Protagonist Therapeutics and 3.5% for UnitedHealth, and the operating margin 58.6% and 5.3%. Revenue was $552M and $450B.

Which is the better investment, Protagonist Therapeutics or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.